Literature DB >> 216238

Postoperative irradiation of glioblastomas. Results in a randomized series.

A P Andersen.   

Abstract

A material of 108 patients with glioblastoma is presented. The series was randomized in two groups: cases only operated upon and cases with postoperative irradiation in addition. Patients dead within 2 months after operation were excluded in estimating the real value of the postoperative irradiation. The irradiated cases had a 6-month survival rate of 64 per cent and a one-year survival rate of 19 per cent; the non-irradiated cases a 6-month survival rate of 28 per cent and a one-year survival rate of 0 per cent.

Entities:  

Mesh:

Year:  1978        PMID: 216238     DOI: 10.3109/02841867809128178

Source DB:  PubMed          Journal:  Acta Radiol Oncol Radiat Phys Biol        ISSN: 0348-5196


  31 in total

1.  Interstitial chemotherapy plus systemic chemotherapy for glioblastoma patients: improved survival in sequential studies.

Authors:  A Boiardi; A Silvani; A Pozzi; L Fariselli; G Broggi; A Salmaggi
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

2.  Radiation therapy of pathologically confirmed newly diagnosed glioblastoma in adults.

Authors:  John Buatti; Timothy C Ryken; Mark C Smith; Penny Sneed; John H Suh; Minesh Mehta; Jeffrey J Olson
Journal:  J Neurooncol       Date:  2008-08-20       Impact factor: 4.130

3.  Macrophage Exclusion after Radiation Therapy (MERT): A First in Human Phase I/II Trial using a CXCR4 Inhibitor in Glioblastoma.

Authors:  Reena P Thomas; Seema Nagpal; Michael Iv; Scott G Soltys; Sophie Bertrand; Judith S Pelpola; Robyn Ball; Jaden Yang; Vandana Sundaram; Jonathan Lavezo; Donald Born; Hannes Vogel; J Martin Brown; Lawrence D Recht
Journal:  Clin Cancer Res       Date:  2019-09-19       Impact factor: 12.531

4.  Development of prognostic index for primary supratentorial intracerebral tumours.

Authors:  J L Hutton; D F Smith; D Sandemann; P M Foy; M D Shaw; I R Williams; D W Chadwick
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-04       Impact factor: 10.154

Review 5.  Delivery of local therapeutics to the brain: working toward advancing treatment for malignant gliomas.

Authors:  Kaisorn L Chaichana; Leon Pinheiro; Henry Brem
Journal:  Ther Deliv       Date:  2015-03

6.  Prognostic factors for high-grade malignant glioma: development of a prognostic index. A Report of the Medical Research Council Brain Tumour Working Party.

Authors: 
Journal:  J Neurooncol       Date:  1990-08       Impact factor: 4.130

7.  Anaplastic astrocytoma.

Authors:  Sean A Grimm; Thomas J Pfiffner
Journal:  Curr Treat Options Neurol       Date:  2013-06       Impact factor: 3.598

8.  Fetal radiation monitoring and dose minimization during intensity modulated radiation therapy for glioblastoma in pregnancy.

Authors:  David P Horowitz; Tony J C Wang; Cheng-Shie Wuu; Wenzheng Feng; Daphnie Drassinower; Anita Lasala; Radoslaw Pieniazek; Simon Cheng; Eileen P Connolly; Andrew B Lassman
Journal:  J Neurooncol       Date:  2014-08-06       Impact factor: 4.130

9.  Nimotuzumab prolongs survival in patients with malignant gliomas: A phase I/II clinical study of concomitant radiochemotherapy with or without nimotuzumab.

Authors:  Jidong Hong; Yuping Peng; Yuping Liao; Wuzhong Jiang; Rui Wei; Lei Huo; Zaide Han; Chaojun Duan; Meizuo Zhong
Journal:  Exp Ther Med       Date:  2012-04-19       Impact factor: 2.447

10.  Combination chemotherapy (COMP protocol) and radiotherapy of anaplastic supratentorial gliomas.

Authors:  K Jellinger; P Kothbauer; D Volc; R Vollmer; R Weiss
Journal:  Acta Neurochir (Wien)       Date:  1979       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.